Inhalation Sciences Sweden AB (publ) (XSAT: ISAB)
Health Care · Life Sciences Tools & Services · SE
Skr0.14
0.00% today · -66.9% 1Y
Inhalation Sciences Sweden AB (publ) (XSAT: ISAB) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $781.25K.
Over the last twelve months the share price has lost 66.9%, trading between 0.13 and 0.59.
Tweenvest scores Inhalation Sciences Sweden AB (publ) across four factors: quality 30/100, value 39/100, growth 0/100. Its strongest factor is value.
ISAB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $781.25K
- Revenue (TTM)
- $670.29K
- P/E
- —
- EPS
- -0.27
- Dividend yield
- —
- Beta (5Y)
- -0.23
- 52-week high
- Skr0.59
- 52-week low
- Skr0.13
- Avg volume (3M)
- —
- Shares outstanding
- 51.20M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.67B | $632.56 | +0.52% |
| Danaher CorporationNYSE: DHR | $153.85B | $220.60 | +0.80% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $72.12B | CN¥162.86 | -3.00% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.61B | CHF590.20 | -0.34% |
| Agilent Technologies, Inc.NYSE: A | $44.91B | $159.16 | +0.10% |
| IQVIA Holdings Inc.NYSE: IQV | $42.77B | $259.82 | +1.47% |
| Waters CorporationNYSE: WAT | $40.35B | $410.39 | -0.08% |
Figures last refreshed Aug 18, 2026.